PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-8.37 Cr | ₹-1.17 Cr | ₹-33 Cr | ₹1,078 Cr | ₹-148 Cr |
What is the latest Consolidated Net Profit of PANACEA BIOTEC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-8.37 Cr |
| Mar2024 | ₹-1.17 Cr |
| Mar2023 | ₹-33 Cr |
| Mar2022 | ₹1,078 Cr |
| Mar2021 | ₹-148 Cr |
How is Consolidated Net Profit of PANACEA BIOTEC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.37 Cr | Negative | |
| Mar2024 | ₹-1.17 Cr | Negative | |
| Mar2023 | ₹-33 Cr | Negative | |
| Mar2022 | ₹1,078 Cr | Positive | |
| Mar2021 | ₹-148 Cr | - | |
Compare Consolidated Net Profit of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,047.4 Cr | 1.9% | -9.6% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 1.9% |
-9.6% |
7.6% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses